Biotechnology Assets, S.A. (BST:041)

Germany flag Germany · Delayed Price · Currency is EUR
0.3600
+0.0210 (6.19%)
At close: Jul 3, 2025
56.52%
Market Cap 27.76M
Revenue (ttm) 2.97M
Net Income (ttm) -2.92M
Shares Out n/a
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.3160
Previous Close 0.3390
Day's Range 0.3160 - 0.3600
52-Week Range 0.1504 - 0.3950
Beta n/a
RSI 64.11
Earnings Date n/a

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. It offers SPLITTERA technology an innovative, universal and robust solution for site-specific conjugation of proteins. Biotechnology Assets, S.A. is based in Cádiz, Spain. [Read more]

Industry Pharmaceutical Preparations
CEO Jaime Feced Rubio
Employees 34
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol 041
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.